Major depressive disorder screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Major depressive disorder}} | {{Major depressive disorder}} | ||
{{CMG}}; {{Mitra}} | {{CMG}}; {{AE}} {{Mitra}} | ||
==Overview== | ==Overview== | ||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
*The U.S. Preventive Services Task Force (USPSTF) does not recommend routine screening for major depressive disorder ([MDD]) in children 7 to 11 years of age. | *The [[U.S. Preventive Services Task Force]] ([[USPSTF]]) does not recommend routine screening for [[major depressive disorder]] ([[MDD]]) in children 7 to 11 years of age. <ref name="pmid26813211">{{cite journal| author=Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW | display-authors=etal| title=Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 4 | pages= 380-7 | pmid=26813211 | doi=10.1001/jama.2015.18392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26813211 }} </ref> | ||
*The USPSTF recommends screening for [[MDD]] in children and adolescents 12 to 18 years of age. | *The USPSTF recommends screening for [[MDD]] in children and adolescents 12 to 18 years of age. <ref name="pmid26813211">{{cite journal| author=Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW | display-authors=etal| title=Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 4 | pages= 380-7 | pmid=26813211 | doi=10.1001/jama.2015.18392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26813211 }} </ref> | ||
**The [[Patient Health Questionnaire for Adolescents]] ([PHQ-A]) and the [[Beck Depression Inventory for Primary Care]] ([BDI-PC]) can be used. | **The [[Patient Health Questionnaire for Adolescents]] ([PHQ-A]) and the [[Beck Depression Inventory for Primary Care]] ([BDI-PC]) can be used. | ||
*The U.S. Preventive Services Task Force (USPSTF) and American Academy of Family Physicians recommend screening for MDD in the general adult population. | *The U.S. Preventive Services Task Force (USPSTF) and American Academy of Family Physicians recommend screening for MDD in the general adult population. | ||
*The USPSTF, American Academy of Family Physicians, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists recommend screening all postpartum women for depression. | *The USPSTF, American Academy of Family Physicians, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists recommend screening all postpartum women for depression. <ref name="pmid26813211">{{cite journal| author=Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW | display-authors=etal| title=Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 4 | pages= 380-7 | pmid=26813211 | doi=10.1001/jama.2015.18392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26813211 }} </ref> <ref name="urlOverview of AAFP Clinical Preventive Services Recommendations">{{cite web |url=https://www.aafp.org/family-physician/patient-care/clinical-recommendations/aafp-cps/overview.html |title=Overview of AAFP Clinical Preventive Services Recommendations |format= |work= |accessdate=}}</ref> <ref name="pmid26813211">{{cite journal| author=Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW | display-authors=etal| title=Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 4 | pages= 380-7 | pmid=26813211 | doi=10.1001/jama.2015.18392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26813211 }} </ref> <ref name="pmid25932866">{{cite journal| author=| title=The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression. | journal=Obstet Gynecol | year= 2015 | volume= 125 | issue= 5 | pages= 1268-1271 | pmid=25932866 | doi=10.1097/01.AOG.0000465192.34779.dc | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25932866 }} </ref> | ||
*The USPSTF recommends that all pregnant women should be screened for depression at least once during the perinatal period. It recommends screening at least once during pregnancy and again 4-8 weeks after delivery. | *The USPSTF recommends that all pregnant women should be screened for depression at least once during the perinatal period. It recommends screening at least once during pregnancy and again 4-8 weeks after delivery. <ref name="pmid26813211">{{cite journal| author=Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW | display-authors=etal| title=Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 4 | pages= 380-7 | pmid=26813211 | doi=10.1001/jama.2015.18392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26813211 }} </ref> | ||
**A validated screening instrument such as the [[Edinburgh Postnatal Depression Scale]] or the [[PHQ-9]] can be used. | **A validated screening instrument such as the [[Edinburgh Postnatal Depression Scale]] or the [[PHQ-9]] can be used. | ||
*In older adults, instruments such as [[PHQ-2]], [[PHQ-9]], [[Cornell Scale for Depression in Dementia]], or [[Geriatric Depression Scale]] are appropriate screening tools. | *In older adults, instruments such as [[PHQ-2]], [[PHQ-9]], [[Cornell Scale for Depression in Dementia]], or [[Geriatric Depression Scale]] are appropriate screening tools. | ||
| Line 19: | Line 19: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
Latest revision as of 01:41, 27 May 2021
|
Major depressive disorder Microchapters |
|
Differentiating Major depressive disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Follow-up |
|
Case Studies |
|
Major depressive disorder screening On the Web |
|
American Roentgen Ray Society Images of Major depressive disorder screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mitra Chitsazan, M.D.[2]
Overview
According to the U.S. Preventive Services Task Force (USPSTF), screening for major depressive disorder is recommended in children and adolescents 12 to 18 years of age, in older adults, and in pregnant women (at least once during pregnancy and again 4-8 weeks after delivery).
Screening
- The U.S. Preventive Services Task Force (USPSTF) does not recommend routine screening for major depressive disorder (MDD) in children 7 to 11 years of age. [1]
- The USPSTF recommends screening for MDD in children and adolescents 12 to 18 years of age. [1]
- The Patient Health Questionnaire for Adolescents ([PHQ-A]) and the Beck Depression Inventory for Primary Care ([BDI-PC]) can be used.
- The U.S. Preventive Services Task Force (USPSTF) and American Academy of Family Physicians recommend screening for MDD in the general adult population.
- The USPSTF, American Academy of Family Physicians, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists recommend screening all postpartum women for depression. [1] [2] [1] [3]
- The USPSTF recommends that all pregnant women should be screened for depression at least once during the perinatal period. It recommends screening at least once during pregnancy and again 4-8 weeks after delivery. [1]
- A validated screening instrument such as the Edinburgh Postnatal Depression Scale or the PHQ-9 can be used.
- In older adults, instruments such as PHQ-2, PHQ-9, Cornell Scale for Depression in Dementia, or Geriatric Depression Scale are appropriate screening tools.
- When any of the screening instruments is positive for possible depression, the diagnosis needs to be confirmed according to the criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW; et al. (2016). "Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (4): 380–7. doi:10.1001/jama.2015.18392. PMID 26813211.
- ↑ "Overview of AAFP Clinical Preventive Services Recommendations".
- ↑ "The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression". Obstet Gynecol. 125 (5): 1268–1271. 2015. doi:10.1097/01.AOG.0000465192.34779.dc. PMID 25932866.